Improvements in quality-of-life dimensions through medium-chain triglyceride (MCT) supplementation in rheumatoid arthritis: updated findings from a randomised clinical trial.

1 Among them, rheumatoid arthritis (RA) is one of the most common, with an estimated prevalence in Europe ranging from 1 to 6/1000 for men and 3 to 12/1000 for women and with an increasing trend from southern to northern countries. 2 Even if primarily involving joint structure, RA must be considered as a systemic disease, due to its extra-articular manifestations. 3 In particular, cardiovascular disease (CVD) is the primary cause of death in RA, with these patients having a 60% increased r

also in 63,971 other papers